Product Images Metoprolol Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Metoprolol Succinate NDC 72516-028 by Oryza Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
50 mg 1000 count - metoprolol 09

This text is a label for a medication containing metoprolol, a drug used to treat high blood pressure and chest pain. The tablet contains 47.5 mg of metoprolol succinate, which is equivalent to 50 mg of metoprolol tartrate. The dosage instructions are provided in the package insert. The medication should be kept out of reach of children and stored at a temperature between 15-30°C (59-86°F). The medication is manufactured by Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. in China for Oryza Pharmaceuticals, Inc. The label also includes contact information for the manufacturer in Coral Springs, FL.*
100 mg 1000 count - metoprolol 10

This text provides information about a medication in the form of tablets containing 95 mg of metoprolol succinate, which is equivalent to 100 mg of metoprolol tartrate, USP. The dosage details are available in the package insert, and a warning to keep the medication out of reach of children. The tablets are to be stored at room temperature with excursions permitted within a certain range. The medication is recommended to be dispensed in a child-resistant container. Additionally, it lists the manufacturer as Oryza Pharmaceuticals, Inc. and the manufacturer's location in China.*
200 mg 100 count - metoprolol 11

This is a description of a medication containing metoprolol succinate, with each tablet containing 190 mg of the active ingredient. It is equivalent to 200 mg of metoprolol tartrate. The dosage information should be referred to in the package insert. The manufacturer is Oryza Pharmaceuticals, Inc. based in Coral Springs, FL, while the manufacturing is done by Zhejlang Apeloa Kangyu Pharmaceutical Co, Ltd. in China. The storage conditions recommend keeping the medication at 25°C (77°F) with excursions allowed to 15-30°C (59-86°F). A warning is provided to keep the medication out of reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.